ASKA Pharmaceutical Co., Ltd.
あすか製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4514
FY2019 · 2020-03-31
| Gross margin | 45.7% |
| Operating margin | 2.9% |
| Net margin | 1.2% |
| Return on equity | 1.6% |
| Return on assets | 0.8% |
| Revenue growth (YoY) | 12.5% |
| EPS (basic) | ¥22.96 |
| EPS growth (YoY) | -62.9% |
| Current ratio | 2.18x |
| Equity ratio | 49.2% |
| Book value / share | ¥1,467.58 |
| Free cash flow | -2,550 M |